Higher CD4+ T-cells during follow-up and higher blood lymphocyte count at the time of transplantation were protective factors against OI (0.31 (0.11–0.83) and 0.61 (0.40–0.95), respectively). This evidence concerns the gene CD4 and osteogenesis imperfecta.